Mar 28, 2023 / 05:00PM GMT
Paul Matteis - Stifel Financial Corp. - Analyst
Great. Good afternoon, everybody. It's my pleasure to be with Ian Mortimer, President and CEO of Xenon. Ian, it's always great to see you. We've done a number of panels together even in the past six months, so sorry to have to deal with me again. And Sherry Aulin, CFO. Sorry, Sherry, you disappeared for a second off of my screen, so I didn't know if [you're in this meeting] or not.
Before we start, Ian, did you run this morning? And if so, how far?
Ian Mortimer - Xenon Pharmaceuticals, Inc. - President and CEO
I did run this morning. I did 10 miles, yeah.
Paul Matteis - Stifel Financial Corp. - Analyst
Okay. Easy day?
Ian Mortimer - Xenon Pharmaceuticals, Inc. - President and CEO
Easy day.
Questions and Answers:
Paul Matteis - Stifel Financial Corp. - AnalystAll right. That's awesome. Cool, okay. With that, do you want to just give us an update of the 1101 pivotal